Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5322 ARTÍCULOS , VIENDO DEL 4996 AL 5010

Effects of Dual Task Training on Dual Task Gait Performance and Cognitive Function in Individuals With Parkinson Disease: A Meta-analysis and Meta-regression

Wong PL, Cheng SJ, Yang YR, Wang RY.

Arch Phys Med Rehabil. 2023 Jun;104(6):950-964. doi: 10.1016/j.apmr.2022.11.001. Epub 2022 Nov 28.

Increased fracture risk in Parkinson's disease - An exploration of mechanisms and consequences for fracture prediction with FRAX

Schini M, Bhatia P, Shreef H, Johansson H, Harvey NC, Lorentzon M, Kanis JA, Bandmann O, McCloskey EV.

Bone. 2023 Mar;168:116651. doi: 10.1016/j.bone.2022.116651. Epub 2022 Dec 24.

Multicenter cohort study on duration of antiarrhythmic medication for supraventricular tachycardia in infants

Mecklin M, Linnanmäki A, Hiippala A, Leino T, Arola A, Leskinen M, Ruotsalainen H, Happonen JM, Poutanen T.

Eur J Pediatr. 2023 Mar;182(3):1089-1097. doi: 10.1007/s00431-022-04757-5. Epub 2022 Dec 28.

Clinical and MRI features of gait and balance disorders in neurodegenerative diseases

Sarasso E, Filippi M, Agosta F.

J Neurol. 2023 Mar;270(3):1798-1807. doi: 10.1007/s00415-022-11544-7. Epub 2022 Dec 28.

A whole new world: embracing the systems-level to understand the indirect impact of pathology in neurodegenerative disorders

Taylor NL, Shine JM.

J Neurol. 2023 Apr;270(4):1969-1975. doi: 10.1007/s00415-022-11550-9. Epub 2022 Dec 29.

SIRT1 pathway in Parkinson's disease: a faraway snapshot but so close

Batiha GE, Al-Kuraishy HM, Al-Gareeb AI, Elekhnawy E.

Inflammopharmacology. 2023 Feb;31(1):37-56. doi: 10.1007/s10787-022-01125-5. Epub 2022 Dec 29.

Premotor, nonmotor and motor symptoms of Parkinson's Disease: A new clinical state of the art

Leite Silva ABR, Gonçalves de Oliveira RW, Diógenes GP, de Castro Aguiar MF, Sallem CC, Lima MPP, de Albuquerque Filho LB, Peixoto de Medeiros SD, Penido de Mendonça LL, de Santiago Filho PC, Nones DP, da Silva Cardoso PMM, Ribas MZ, Galvão SL, Gomes GF, Bezerra de Menezes AR, Dos Santos NL, Mororó VM, Duarte FS, Dos Santos JCC.

Ageing Res Rev. 2023 Feb;84:101834. doi: 10.1016/j.arr.2022.101834. Epub 2022 Dec 26.

Permanent non-progressive cinnarizine and flunarizine-induced parkinsonism: An under-recognized tardive syndrome in the elderly?

Calzetti S, Negrotti A.

J Neurol Sci. 2023 Jan 15;444:120526. doi: 10.1016/j.jns.2022.120526. Epub 2022 Dec 17.

Lateral flow assays for detection of disease biomarkers

Gumus E, Bingol H, Zor E.

J Pharm Biomed Anal. 2023 Feb 20;225:115206. doi: 10.1016/j.jpba.2022.115206. Epub 2022 Dec 20.

The effect of mobile application-based rehabilitation in patients with Parkinson's disease: A systematic review and meta-analysis

Özden F.

Clin Neurol Neurosurg. 2023 Feb;225:107579. doi: 10.1016/j.clineuro.2022.107579. Epub 2022 Dec 28.

Nutrigenomics in Parkinson's disease: diversity of modulatory actions of polyphenols on epigenetic effects induced by toxins

Rodrigues-Costa M, Fernandes MSS, Jurema-Santos GC, Gonçalves LVDP, Andrade-da-Costa BLDS.

Nutr Neurosci. 2023 Jan;26(1):72-84. doi: 10.1080/1028415X.2021.2017662. Epub 2022 Jan 4.

Editorial: The underlying relationship between sleep and neurodegenerative diseases

Piñol-Ripoll G, Lima MMS, Li SB, Targa ADS.

Front Neurosci. 2023 Jan 5;16:1117265. doi: 10.3389/fnins.2022.1117265. eCollection 2022.

E, K, B5, B6, and B9 vitamins and their specific immunological effects evaluated by flow cytometry

Munteanu C, Berindean I, Mihai M, Pop B, Popa M, Muntean L, Petrescu O, Ona A.

Front Med (Lausanne). 2023 Jan 5;9:1089476. doi: 10.3389/fmed.2022.1089476. eCollection 2022.

Comparative efficacy of transcranial magnetic stimulation on different targets in Parkinson's disease: A Bayesian network meta-analysis

Dong K, Zhu X, Xiao W, Gan C, Luo Y, Jiang M, Liu H, Chen X.

Front Aging Neurosci. 2023 Jan 4;14:1073310. doi: 10.3389/fnagi.2022.1073310. eCollection 2022.

Editorial: Targeting the endocannabinoidome in neurodegenerative disorders

Ishiguro H.

Front Aging Neurosci. 2023 Jan 4;14:1116635. doi: 10.3389/fnagi.2022.1116635. eCollection 2022.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias